Left ventricular twist in hypertrophic cardiomyopathy : Predictor of nonsustained ventricular tachycardia

O Candan1, C Gecmen2, A Kalaycı2

  • 1Cardiology Clinic, Kartal Kosuyolu Heart Training and Research Hospital, 34846, Kartal, İstanbul, Turkey. oz_candan@hotmail.com.

Herz
|October 18, 2017
PubMed

Insights

In hypertrophic cardiomyopathy (HCM) patients, decreased global longitudinal peak strain (GLPS) and increased twist are key predictors of nonsustained ventricular tachycardia (NsVT). Speckle-tracking echocardiography (STE) parameters can help identify at-risk individuals.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Arrhythmology

Background:

  • Hypertrophic cardiomyopathy (HCM) is a significant cause of sudden cardiac death.
  • Nonsustained ventricular tachycardia (NsVT) is a common complication in HCM patients.
  • Predicting NsVT risk is crucial for timely intervention and improved patient outcomes.

Purpose of the Study:

  • To evaluate the predictive value of clinical and echocardiographic parameters for NsVT in HCM.
  • To assess the role of speckle-tracking echocardiography (STE) in identifying NsVT risk.
  • To determine specific echocardiographic markers associated with NsVT occurrence.

Main Methods:

  • A cohort of 59 HCM patients underwent clinical assessment, ECG, and echocardiography (2D and STE).
  • Holter monitoring was performed within 24-72 hours to detect NsVT.
  • Patients were grouped based on the presence or absence of NsVT.

Main Results:

  • NsVT was detected in 29% of patients.
  • Higher twist and apical rotation, along with decreased global longitudinal peak strain (GLPS), were observed in patients with NsVT.
  • Multivariate analysis identified GLPS (OR: 1.406) and twist (OR: 1.236) as independent predictors of NsVT.

Conclusions:

  • Decreased GLPS and increased twist are significant predictors of NsVT in HCM.
  • Easily measurable STE parameters can aid in identifying HCM patients at higher risk for arrhythmia.
  • These findings support the use of STE for risk stratification in HCM management.
Abstract

Related Concept Videos

Dysrhythmias III: Characteristics of Dysrhythmias01:29

Dysrhythmias III: Characteristics of Dysrhythmias

Dysrhythmias, also known as arrhythmias, are irregular heart rhythms that result from abnormal electrical activity in the heart, affecting its ability to circulate blood efficiently. Tachyarrhythmias, a subset of dysrhythmias, are characterized by abnormally fast heart rates exceeding 100 beats per minute. Here are some types of tachyarrhythmias with their distinct ECG features:Sinus Tachycardia:Sinus tachycardia presents a regular heart rhythm with an increased rate of 101-180 beats per minute.
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...